Product Information

CEFPROZIL 250 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1655 per ML under NDC 65862010075. Its NADAC has been published 613 times since Nov 28, 2013.

CEFPROZIL 250 MG/5 ML SUSP

Cefprozil
$0.1655per ML

Strength

250 mg/5mL

NDC

65862010075

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

8/20/2025

Active Ingredients

CEFPROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065381

On Market Since

1/30/2007

Price Statistics

The NADAC for CEFPROZIL 250 MG/5 ML SUSP has been published 613 times since Nov 28, 2013, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1655 per ML
All-time high$0.5641 (Jun 11, 2014)
All-time low$0.1433 (Aug 21, 2024)
52-week high$0.1766
52-week low$0.1655
Median price$0.2935
Average price$0.3389
Largest weekly change+58.3% (Feb 23, 2022)
Weeks tracked613
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-6.3%

3Y

-26.5%

5Y

-22.2%

All

-70.3%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CEFPROZIL 250 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.1655 per ML (NDC 65862010075), effective Aug 20, 2025.

How has the price of CEFPROZIL 250 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has declined 70.3%. It has been tracked across 613 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has ranged from a low of $0.1433 (Aug 21, 2024) to a high of $0.5641 (Jun 11, 2014), with a median of $0.2935 per ML.

Are there cheaper alternatives to CEFPROZIL 250 MG/5 ML SUSP?

3 NADAC-published products share the same active ingredient, strength, and dosage form as CEFPROZIL 250 MG/5 ML SUSP, but none are currently priced below it.

Who manufactures CEFPROZIL 250 MG/5 ML SUSP?

CEFPROZIL 250 MG/5 ML SUSP (NDC 65862010075) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.